491 related articles for article (PubMed ID: 26839093)
21. RET genetic screening in patients with medullary thyroid cancer and their relatives: experience with 807 individuals at one center.
Elisei R; Romei C; Cosci B; Agate L; Bottici V; Molinaro E; Sculli M; Miccoli P; Basolo F; Grasso L; Pacini F; Pinchera A
J Clin Endocrinol Metab; 2007 Dec; 92(12):4725-9. PubMed ID: 17895320
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic and surgical dilemmas in hereditary medullary thyroid carcinoma.
Allen SM; Bodenner D; Suen JY; Richter GT
Laryngoscope; 2009 Jul; 119(7):1303-11. PubMed ID: 19444888
[TBL] [Abstract][Full Text] [Related]
23. RET proto-oncogene: a review and update of genotype-phenotype correlations in hereditary medullary thyroid cancer and associated endocrine tumors.
Kouvaraki MA; Shapiro SE; Perrier ND; Cote GJ; Gagel RF; Hoff AO; Sherman SI; Lee JE; Evans DB
Thyroid; 2005 Jun; 15(6):531-44. PubMed ID: 16029119
[TBL] [Abstract][Full Text] [Related]
24. Medullary thyroid carcinoma.
Pacini F; Castagna MG; Cipri C; Schlumberger M
Clin Oncol (R Coll Radiol); 2010 Aug; 22(6):475-85. PubMed ID: 20627492
[TBL] [Abstract][Full Text] [Related]
25. Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto-oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal.
Prazeres HJ; Rodrigues F; Figueiredo P; Naidenov P; Soares P; Bugalho MJ; Lacerda M; Campos B; Martins TC
Clin Endocrinol (Oxf); 2006 Jun; 64(6):659-66. PubMed ID: 16712668
[TBL] [Abstract][Full Text] [Related]
26. Advances and controversies in the diagnosis and management of medullary thyroid carcinoma.
Heshmati HM; Gharib H; van Heerden JA; Sizemore GW
Am J Med; 1997 Jul; 103(1):60-9. PubMed ID: 9236487
[TBL] [Abstract][Full Text] [Related]
27. RET oncogene in MEN2, MEN2B, MTC and other forms of thyroid cancer.
Lodish MB; Stratakis CA
Expert Rev Anticancer Ther; 2008 Apr; 8(4):625-32. PubMed ID: 18402529
[TBL] [Abstract][Full Text] [Related]
28. Chinese siblings with hereditary medullary thyroid carcinoma caused by RET mutation: implications for RET oncogene detection.
Huang Q; Hu A; Zhang M
BMC Endocr Disord; 2020 May; 20(1):64. PubMed ID: 32408902
[TBL] [Abstract][Full Text] [Related]
29. Mutation analysis of the RET proto-oncogene and early thyroidectomy: results of a Portuguese cancer centre.
Bugalho MJ; Domingues R; Santos JR; Catarino AL; Sobrinho L
Surgery; 2007 Jan; 141(1):90-5. PubMed ID: 17188172
[TBL] [Abstract][Full Text] [Related]
30. Molecular genetics and phenomics of RET mutations: Impact on prognosis of MTC.
Frank-Raue K; Rondot S; Raue F
Mol Cell Endocrinol; 2010 Jun; 322(1-2):2-7. PubMed ID: 20083156
[TBL] [Abstract][Full Text] [Related]
31. High prevalence of exon 8 G533C mutation in apparently sporadic medullary thyroid carcinoma in Greece.
Sarika HL; Papathoma A; Garofalaki M; Vasileiou V; Vlassopoulou B; Anastasiou E; Alevizaki M
Clin Endocrinol (Oxf); 2012 Dec; 77(6):857-62. PubMed ID: 22676047
[TBL] [Abstract][Full Text] [Related]
32. The modifier role of RET-G691S polymorphism in hereditary medullary thyroid carcinoma: functional characterization and expression/penetrance studies.
Colombo C; Minna E; Rizzetti MG; Romeo P; Lecis D; Persani L; Mondellini P; Pierotti MA; Greco A; Fugazzola L; Borrello MG
Orphanet J Rare Dis; 2015 Mar; 10():25. PubMed ID: 25887804
[TBL] [Abstract][Full Text] [Related]
33. RET mutation status in medullary thyroid cancer(MTC) patients and the significance of genetic screening for mutations in their immediate relatives--a preliminary report.
Menon MM; Simha MR
Indian J Pathol Microbiol; 2005 Apr; 48(2):161-5. PubMed ID: 16758654
[TBL] [Abstract][Full Text] [Related]
34. Detection of Molecular Alterations in Medullary Thyroid Carcinoma Using Next-Generation Sequencing: an Institutional Experience.
Wei S; LiVolsi VA; Montone KT; Morrissette JJ; Baloch ZW
Endocr Pathol; 2016 Dec; 27(4):359-362. PubMed ID: 27379493
[TBL] [Abstract][Full Text] [Related]
35. A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma.
Romei C; Ciampi R; Elisei R
Nat Rev Endocrinol; 2016 Apr; 12(4):192-202. PubMed ID: 26868437
[TBL] [Abstract][Full Text] [Related]
36. Genotype-phenotype based surgical concept of hereditary medullary thyroid carcinoma.
Machens A; Dralle H
World J Surg; 2007 May; 31(5):957-68. PubMed ID: 17453286
[TBL] [Abstract][Full Text] [Related]
37. RET proto-oncogene testing in infants presenting with Hirschsprung disease identifies 2 new multiple endocrine neoplasia 2A kindreds.
Fialkowski EA; DeBenedetti MK; Moley JF; Bachrach B
J Pediatr Surg; 2008 Jan; 43(1):188-90. PubMed ID: 18206480
[TBL] [Abstract][Full Text] [Related]
38. Medical management of metastatic medullary thyroid cancer.
Maxwell JE; Sherman SK; O'Dorisio TM; Howe JR
Cancer; 2014 Nov; 120(21):3287-301. PubMed ID: 24942936
[TBL] [Abstract][Full Text] [Related]
39. Update on the Treatment of Medullary Thyroid Carcinoma in Patients with Multiple Endocrine Neoplasia Type 2.
Ilanchezhian M; Khan S; Okafor C; Glod J; Del Rivero J
Horm Metab Res; 2020 Aug; 52(8):588-597. PubMed ID: 32299110
[TBL] [Abstract][Full Text] [Related]
40. [Medullary thyroid carcinoma in children].
Berdelou A; Hartl D; Al Ghuzlan A; Mirghani H; Chougnet C; Baudin E; Schlumberger M; Leboulleux S
Bull Cancer; 2013; 100(7-8):780-8. PubMed ID: 23831771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
